These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29157884)

  • 1. CISNE or MASCC, which predictor is really the weakest in febrile neutropenia?
    Carmona-Bayonas A; Jiménez-Fonseca P
    Eur J Intern Med; 2018 Apr; 50():e33-e34. PubMed ID: 29157884
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.
    Ahn S; Rice TW; Yeung SJ; Cooksley T
    Support Care Cancer; 2018 May; 26(5):1465-1470. PubMed ID: 29168032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis.
    Zheng B; Toarta C; Cheng W; Taljaard M; Reaume N; Perry JJ
    Crit Rev Oncol Hematol; 2020 May; 149():102922. PubMed ID: 32244162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CISNE versus MASCC: Identifying low risk febrile neutropenic patients.
    Mohindra R; Mathew R; Yadav S; Aggarwal P
    Am J Emerg Med; 2020 Nov; 38(11):2259-2263. PubMed ID: 31864874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.
    Coyne CJ; Le V; Brennan JJ; Castillo EM; Shatsky RA; Ferran K; Brodine S; Vilke GM
    Ann Emerg Med; 2017 Jun; 69(6):755-764. PubMed ID: 28041827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
    Ono Y; Hayama N; Hattori S; Ito Y; Oguma T; Sakamaki F; Asano K
    Thorac Cancer; 2022 Dec; 13(24):3504-3509. PubMed ID: 36330990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?
    Chen AY; Gottlieb M; Vilke GM; Coyne C
    J Emerg Med; 2023 Jan; 64(1):111-118. PubMed ID: 36641256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.
    Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela Echaburu J; Antonio M; Font C; Biosca M; Ramchandani A; Martínez J; Hernando Cubero J; Espinosa J; Martínez de Castro E; Ghanem I; Beato C; Blasco A; Garrido M; Bonilla Y; Mondéjar R; Arcusa Lanza MÁ; Aragón Manrique I; Manzano A; Sevillano E; Castañón E; Cardona M; Gallardo Martín E; Pérez Armillas Q; Sánchez Lasheras F; Ayala de la Peña F
    J Clin Oncol; 2015 Feb; 33(5):465-71. PubMed ID: 25559804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia.
    Sütcüoğlu O; Akdoğan O; Gürler F; Kurt İnci B; Özdemir N; Özet A; Yazıcı O
    Int J Clin Pract; 2021 Jul; 75(7):e14185. PubMed ID: 33783936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?
    Moon H; Choi YJ; Sim SH
    PLoS One; 2018; 13(12):e0210019. PubMed ID: 30596803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients.
    Monuszko KA; Albright B; Katherine Montes De Oca M; Thao Thi Nguyen N; Havrilesky LJ; Davidson BA
    Gynecol Oncol Rep; 2021 Aug; 37():100853. PubMed ID: 34504931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors.
    Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela J; Antonio M; Font C; Biosca M; Ramchandani A; Martinez-Garcia J; Hernando J; Espinosa J; de Castro EM; Ghanem I; Beato C; Blasco A; Garrido M; Mondéjar R; Arcusa MÁ; Aragón I; Manzano A; Sevillano E; Castañón E; Ayala F;
    Clin Transl Oncol; 2017 Mar; 19(3):386-395. PubMed ID: 27525978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis".
    Ghajari H; Sabour S
    Crit Rev Oncol Hematol; 2020 Nov; 155():103089. PubMed ID: 32927334
    [No Abstract]   [Full Text] [Related]  

  • 14. The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.
    Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela Echaburu J; Sánchez Cánovas M; Ayala de la Peña F
    Clin Transl Oncol; 2017 Sep; 19(9):1084-1090. PubMed ID: 28289961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk scores for outpatient management of febrile neutropenia: Is the MASCC slipping?
    Cooksley T; Ahn S; Knight T; Rice TW
    Eur J Intern Med; 2018 Apr; 50():e35-e36. PubMed ID: 29217281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score.
    Uys A; Rapoport BL; Anderson R
    Support Care Cancer; 2004 Aug; 12(8):555-60. PubMed ID: 15197637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis prediction of febrile neutropenia by MASCC score: A retrospective study].
    Cervetti L; Vallard A; Le Moulec S; Espenel S; Falk AT; Ben Mrad M; Guy JB; Diao P; Méry B; Langrand-Escure J; Ferrand FR; Rivoirard R; Ceccaldi B; Védrine L; Magné N; Chargari C
    Bull Cancer; 2016 Jun; 103(6):561-70. PubMed ID: 27181759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study.
    Bhardwaj PV; Emmich M; Knee A; Ali F; Walia R; Roychowdhury P; Clark J; Sridhar A; Lagu T; Loh KP
    Support Care Cancer; 2021 Oct; 29(10):5905-5914. PubMed ID: 33761002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculated decisions: MASCC Risk Index for febrile neutropenia.
    Taylor J
    Emerg Med Pract; 2018 Jan; 20(Suppl 1):3-4. PubMed ID: 29323859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.